Curaleaf Holdings, Inc. is a cannabis company involved in the retail and wholesale of cannabis products across the U.S. and internationally. Key strengths include a solid gross margin of 50% and a decent current ratio of 1.52, indicating good liquidity. However, concerns arise from low net margins of 3.7% and a return on equity (ROE) of only 1.4%, suggesting profitability challenges. Despite high margins, the overall financial health score of 52/100 indicates potential operational inefficiencies that investors should monitor.
Loading financial metrics...
Debt of $779.2M is 7.3x the company's cash position of $107.0M.
Exceptional revenue growth of 37.4% YoY demonstrates strong market demand and competitive positioning.
Both gross margin (+0.8pp) and operating margin (+1.1pp) are expanding simultaneously, indicating the company is scaling profitably.
Operating cash flow surged 52.9% YoY, indicating strong cash generation capability.
Free cash flow increased 122.0% YoY, enhancing capital allocation optionality.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q2 (June 30, 2026)